Drug Interactions between clomipramine and Tyblume
This report displays the potential drug interactions for the following 2 drugs:
- clomipramine
- Tyblume (ethinyl estradiol/levonorgestrel)
Interactions between your drugs
ethinyl estradiol clomiPRAMINE
Applies to: Tyblume (ethinyl estradiol / levonorgestrel) and clomipramine
Information for this minor interaction is only available at a professional reading level.
Drug and food interactions
levonorgestrel food
Applies to: Tyblume (ethinyl estradiol / levonorgestrel)
Grapefruit juice may increase the blood levels of certain medications such as levonorgestrel. You may want to limit your consumption of grapefruit and grapefruit juice during treatment with levonorgestrel. However, if you have been regularly consuming grapefruit or grapefruit juice with the medication, then it is advisable for you to talk with your doctor before changing the amounts of these products in your diet, as this may alter the effects of your medication. Contact your doctor if your condition changes or you experience increased side effects. Orange juice is not expected to interact.
clomiPRAMINE food
Applies to: clomipramine
Grapefruit, grapefruit juice, and cranberry juice may cause the clomiPRAMINE levels in your body to increase. This may lead to potentially dangerous adverse effects. If you are receiving clomiPRAMINE therapy and consume cranberry juice or grapefruit products, you should be monitored for adverse effects and changes in clomiPRAMINE levels. Do not increase or decrease the amount of cranberry juice or grapefruit products in your diet without first talking to your doctor.
ethinyl estradiol food
Applies to: Tyblume (ethinyl estradiol / levonorgestrel)
Information for this minor interaction is only available at a professional reading level.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See Also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.